PTC Therapeutics Exec. VP and CLO Mark Elliott Boulding disposes of 2,813 common shares worth $204,863.91 - PTCT News | RalliesPTC Therapeutics Exec. VP and CLO Mark Elliott Boulding disposes of 2,813 common shares worth $204,863.91
P
PTCT• Executive share sale after option exercise
- PTC Therapeutics Executive VP and CLO Mark Elliott Boulding cut his stake to 105,272 shares in transactions dated Aug. 17.
- Sale of 2,813 shares followed an option exercise at USD 25.69 per share.
- Disposed of 2,813 shares at weighted average prices of USD 72.39 and USD 72.9 per share.
COTY
•
